Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Acierno L (1989) Cardiac complications in acquired immunodeficiency syndrome (AIDS): a review. J Am Coll Cardiol 13: 1144 ff.
Ainger WH, Lorell BH (1989) Challenge of cardiomyopathy. J Am Coll Cardiol 13: 1219–1239
Anderson JL, Fowles RE, Unverferth DV, Mason JW (1987) Immunosuppressive therapy of myocardial inflammatory disease — initial experience and further trials to define indications for therapy. Eur Heart J 8(Suppl J): 263–266
Archard LC, Freeke CA, Richardson PJ, Schultheiβ HP (eds) (1987) Persistence of enterovirus RNA in dilated cardiomyopathy: a progression of myocarditis. New concepts in viral heart disease. Springer, Berlin Heidelberg New York, pp 347–362
Badorff C, Berkeley N, Mehrotra S et al. (2000) Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J Biol Chem 275: 11191–11197
Barbaro G, Di Lorenzo G et al. (1998a) Cardiac involvement in the acquired immunodeficiency syndrome. A multicenter clinical-pathological study. AIDS Res Hum Retroviruses 14: 1071–1077
Barbaro G, Di Lorenzo G et al. (1998b) Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 339: 1093–1099
Barry WH (1994) Mechanisms of immune-mediated myocyte injury. Circulation 89: 2421–2432
Böhm M, Ungerer M, Erdmann E (1990) Beta adrenoceptors und mcholinoceptors in myocardium of hearts with coronary artery disease or idiopathic dilated cardiomyopathy removed at cardiac transplantation. Am J Cardiol 66: 880–882
Bowles NE, Richardson PJ, Olsen EGJ, Archard LC (1986) Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1: 1120–1123
Bowles NE, Ni J, Kearny DL et al. (1997) Identification of viral causes of cardiac complications associated with HIV infection in children. Pediatrics 100: 429–430
Bowles NE, Kearny DL, Ni J et al. (1999) The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. J Am Coll Cardiol 34: 857–865
Challoner DR, Prols HG (1972) Free fatty acid oxidation and carnitine levels in diphteritic guinea pig myocardium. J Clin Invest 51: 2071 ff.
Chien KR, Knowlton KU, Zu H, Chien S (1991) Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiological response. FASEB J 5: 3037–3046
CIBIS-II Investigators (1999) The Cardiac Insufficiency Bisoprolol Study II: a randomized trial. Lancet 353: 9–13
Cohn JN, Johnson G Ziesche S et al. (1991) A comparison of enalapril with hydrolazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325: 303–310
Cooper DKC, Sturridge MF (1976) Constrictive pericarditis following coxsackie virus infection. Thorax 31: 472 ff.
Currie PF, Jacob AJ, Foreman AR et al. (1994) Heart muscle disease related to HIV infection: prognostic implications. MBJ 309: 1605–1607
D’Amati G, Di Gioia CR, Gallo P (2001) Pathological findings of HIV-associated cardiovascular disease. Ann N Y Acad Sci 946: 23–45
Dec GW, Fuster V (1994) Medical progress: idiopathic dilated cardiomyopathy. N Engl J Med 331: 1564 ff.
Dörffel WV, Felix, SB, Wallukat G et al. (1997) Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 95: 1994–1997
Drucker NA, Colan SD, Lewis AB et al. (1994) Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 89: 252 ff.
Fenoglio JF, Cersell PC, Kellogg CF et al. (1983) Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med 308: 12–18
Franz WM, Cremer M, Herrmann R et al. (1995) X-linked dilated cardiomyopathy. Novel mutation of the dystrophin gene. Ann NY Acad Sci 752: 470–491
Giacca U, Severnici GM, Mestroni L et al. (1994) Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 24: 1033–1040
Gowrishankar K, Rajajee S (1994) Varied manifestations of viral myocarditis. Indian J Pediatr 61: 75 ff.
Grody WW, Cheng L, Lewis W (1990) Infection of the heart by the human immunodeficiency virus. Am J Cardiol 66: 203 ff.
Grunig E, Tasman JA, Kucherer A et al. (1998) Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31: 186–194
Hallengren B, Forsgren A, Melander A (1982) Influence of β-adrenoceptor blocking agents on lymphocyte function in vitro. Br J Clin Pharmacol 13: 543–546
Huber S (1997) Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic response in different strains of mice. Lab Invest 76: 691–701
Hufnagel G, Pankuweit S, Richter A et al. (2000) The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESTECID). First epidemiological results. Herz 25: 279–285
Joy J, Rao YY, Raveendranath M et al. (1990) Coxsackie viral myocarditis: a clinical and echocardiographic study. Indian Heart J 42: 441 ff.
Kandolf R (1998) Enterovirale Myokarditis und dilatative Kardiomyopathie. Med Klin 93: 215–222
Kandolf R, Ameis D, Kirchner P et al. (1987) In situ detection of enteroviral genomes in myocardial cells by nucliec acid hybridization: an approach to the diagnosis viral heart disease. Proc Natl Acad Sci USA 84: 6272–6276
Kandolf R, Kirschner P, Ameis D et al. (eds) (1988) Enteroviral heart disease: diagnosis by in situ hybridization. New concepts in viral heart disease. Springer, Berlin Heidelberg New York, pp 337–348
Kim HS, Sohn S, Park JY, Seo JW (2004) Fulminant myocarditis successfully treated with high-dose immunoglobulin. Int J Cardiol 96: 485–486
Kühl U, Pauschinger M, Schwimmbeck PL et al. (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107: 2793–2798
Kunkel B, Schneider M, Hübner K, Kaltenbach M (1985) Bioptische und autoptische Häufigkeit der Myokarditis. Z Kardiol 74: 360–368
Levy WS, Simon GL, Rios JC, Ross AM (1989) Prevalence of cardiac abnormalities in human immunodeficiency virus infection. Am J Cardiol 63: 86 ff.
Lieberman EB, Hutchins GM, Herskowitz A et al. (1991) J Am Coll Cardiol 18: 1617–1626
Liggett SB, Wagoner LE, Craft LL et al. (1998) The IIe 164 β2-adrenergic receptor Polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 102: 1534–1539
Lipshultz SE, Fox CH, Perez-Atayde AR et al. (1990) Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol 66: 246–250
Lipshultz SE und die Mitglieder der (P2C2 HIV) Study Group (1998) Left ventricular structure and function in children infected with human immunodeficiency virus. The prospective P2C2 HIV multicenter study. Circulation 97: 1246–1256
Maisch B, Deeg P, Liebau G, Kochsiek K (1983) Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 52: 1072–1078
Maisch B, Schoian U, Hengstenberg C et al. (1994) Immunosuppressive treatment in autoreactive myocarditis: results from a controlled trial. Postgrad Med J 70(Suppl 1): 29–34
Maisch B, Herzum M, Hufnagel G, Schonian U (1996) Immunosuppressive and immunomodulatory treatment for myocarditis. Curr Opin Cardiol 11: 310–324
Maisch B, Portig I, Ristic A et al. (2000) Definition of inflammatory cardiomyopathy (myocarditis) on the way to consensus. Herz 25: 200–209
Manolio TA, Baughman KL, Rodeheffer R et al. (1992) Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung and Blood Institute workshop). Am J Cardiol 59: 1458 ff.
Martin AB, Webber S, Fricker FJ et al. (1994) Acute myocarditis — Rapid diagnostic in children. Circulation 90: 330–339
Martino TA, Liu P, Sole MJ (1994) Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74: 182–188
Mason J, Al E (1995) A clinical trial of immunosuppressive therapy for myocarditis: the myocarditis treatment trial investigators. New Engl J Med 333: 269–275
McCarthyIII RE, Boehmer JP, Hruban RH et al. (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342: 690–695
McManus BM, Chow LH, Wilson JE et al. (1993) Direct myocardial injury by enterovirus:a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 68: 159–169
McNamara DM, Rosenblum WD, Janosko KM et al. (1997) Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 95: 2476–2478
MERIT-HF study group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure (MERIT-HF). Lancet 353: 2001–2007
Milei J, Grana D, Fernandez G, Matturr L (1998) Cardiac involvement in acquired immunodeficiency syndrome — a review to push action. The committee for the study of cardiac involvement in AIDS. Clin Cardiol 21(7): 465–472
Muckelbauer JK, Kremer M, Minor I et al. (1995) The structure of coxsackievirus B3 at 3.5A resolution. Structure 3: 653–667
Müller J, Wallukat G, Dandel M et al. (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101: 385–391
Nishio R, Matsumori A, Shioi T et al. (1998) Denopamine, a ß1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis. J Am Coll Cardiol 32: 808–815
Nishio R, Shioi T, Sasayama S, Matsumori A (2003) Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. J Am Coll Cardiol 41: 340–345
Noutsias M, Seeberg B, Schultheiss HP, Kühl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99: 2124–2131
O’Connell JB (1989) Immunosuppression for dilated cardiomyopathy. N Engl J Med 321: 1119 ff.
Olinde KD, O’Connell JB (1994) Inflammatory heart disease: pathogenesis, clinical manifestations and treatment of myocarditis. Ann Rev Med 45: 481 ff.
Pauschinger M, Kühl U, Dörner A et al. (1998) Nachweis enteroviraler RNA in endomyokardialen Biopsien bei inflammatorischer Kardiomyopathie und idiopathischer dilatativer Kardiomyopathie. Z Kardiol 87: 443–452
Pauschinger M, Bowles NE, Fuentes-Garcia FJ et al. (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99: 1348–1354
Peters NS, Poole-Wilson PA (1991a) Myocarditis — continuing clinical and pathologic confusion. Am Heart J 121: 942 ff.
Peters NS, Poole-Wilson PA (1991b) Myocarditis — a controversial disease. J R Soc Med 84: 1 ff.
Pitt B, Zannad F, Remme WJ et al. (1999) The RALES trial: the effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341: 709–717
Pitt B, Williams G, Remme W et al. (2001) The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Cardiovasc Drugs Ther 15: 79–87
Ramos A, Elias P, Barrucand L, DaSilva J (1984) The protective effect of carnitine in human diphteritic myocarditis. Pediatr Res 18: 815 ff.
Rebolledo MA, Krogstad P, Chen F et al. (1998) Infection of human fetal cardiac myocytes by a human immunodeficiency virus-1-derived vector. Circ Res. 83: 738–742
Remes J, Helin M, Vaino P, Rautio P (1990) Clinical outcome and left ventricular function 23 years after acute coxsackie virus myopericarditis. Eur Heart J 11: 182 ff.
Richardson P, McKenna W und die Mitglieder des Kommittees (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93: 841–842
Rueckert RR, Fields BN, Minor I (eds) (1990) Picornaviridae: The viruses and their replication. Virology. Lippincott-Raven Philadelphia, pp 609–654
Schmalz AA, Demel KP, Kallenberg R et al. (1998) Immunosuppressive therapy of chronic myocarditis in children: three cases and the design of a randomized prospective trial of therapy. Pediatr Cardiol 19: 235–239
Schönian U, Maisch B (1992) Zytomegalievirusassoziierte Erkrankungen des Herzens. Herz 17: 85–90
Schönian U, Hufnagel G, Maisch B, Doerr HW (1994) Detection of enterovirus nucleic acids in endomyocardial biopsies of patients with myocarditis and dilated cardiomyopathy. Eur Heart J 15(Suppl): 463
Schultheiß HP (1993a) Die dilatative Kardiomyopathie — eine chronische Myokarditis? Neue Aspekte zur Diagnostik und Therapie. Z Kardiol 83(Suppl 4): 25–33
Schultheiß HP (1993b) The significance of autoantibodies against the ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy — clinical and experimental data. Semin Immunopathol 68: 229–233
Selinka HC, Huber M, Pasch A et al. (1998) Coxsackie B virus and its interaction with permissive host cells. Clin Diagn Virol 9: 115–123
Shafren D, Bates RC, Agrez MV et al. (1995) Coxsackie virus B1, B3 and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 69: 3873–3877
SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327: 685–691
SoRelle R (1998) Vascular and lipid syndromes in selected HIV-infected patients. Circulation 9: 829–830
Strauer BE (1977) Die quantitative Bestimmung der Koronarreserve zur Diagnostik koronarer Durchblutungsstörungen. Internist 18: 579–587
Strauer BE, Kandolf R, Mall G et al. (1994) Konsensus-Bericht: Myokarditis — Kardiomyopathie. Med Klin 89(Suppl 1): 23–38
Strauer BE, Kandolf R, Mall G et al. (2001) Update 2001. Myokarditis — Kardiomyopathie. Med Klin 96: 608–625
Takada H, Kishimoto C, Hiaoka Y (1995) Therapy with immunoglobulin suppresses myocarditis in a murine Coxsackievirus B3 model. Circulation 92: 1604–1611
Teragawa H, Hondo T, Amano H et al. (1996) Cardiogenic shock following recombinant alpha-2b interferon therapy for chronic hepatitis C: a case report. Jpn Heart J 37: 137–142
Tracy SM, Chapman NM, McManus BM et al. (1990) A molecular and serologic evaluation of enteroviral involvement in human Tschöpe C, Westermann D, Steendijk P et al. (2004) Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. Eur J Pharmacol 491: 173–179
Tschöpe C, Westermann D, Steendijk P et al (2004) Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. Eur J Pharmacol 491: 173–179
Why H, Meany T, Richardson P et al. (1994) Clinical and prognostic significance of detectionof enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89: 2582–2589
Yuan Z, Shioji K, Kihara Y et al. (2004) Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property. Am J Physiol Heart Circ Physiol 286: H 83–90
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Schwinger, R.H.G., Reuter, H. (2006). Virale Herzerkrankungen. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29425-2_16
Download citation
DOI: https://doi.org/10.1007/3-540-29425-2_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23742-6
Online ISBN: 978-3-540-29425-2
eBook Packages: Medicine (German Language)